Featured
Peer-Reviewed Publication: Integrative Framework for Thyroid & Endocrine Resilience
Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category leadership.
Vitamin B12, Vitamin D, and Healthy Immune Function*: What Antibody Levels Can Tell Us About the ...
An often observed gap between laboratory normalization and how a person feels has prompted a broader line of inquiry when treating thyroid imbalances. Rather than focusing exclusively on thyroid hormone output, research has increasingly explored how nutritional status and immune activity intersect with thyroid health. In this context, vitamin B12, vitamin D, and healthy immune function have emerged as commonly evaluated variables, particularly in relation to their ability to support healthy thyroid function.* [2-4]
Read now
Thyroid Hormone Signaling in Hypothyroidism: Rethinking Normal
Emerging evidence suggests that hypothyroidism is not simply a condition of low hormone levels, but one of altered signaling across interconnected systems. For many individuals, levothyroxine successfully restores that signaling. For others, factors such as impaired T4-to-T3 conversion, metabolic stress, nutrient inadequacy , immune activity, or altered energy allocation may limit full physiologic recovery, even when laboratory targets are met. [1]
A more integrative, individualized treatment approach creates space for shared decision-making, thoughtful evaluation of contributing factors, and, when appropriate, carefully monitored adjustments in therapy. Effective thyroid care ultimately aims for more than normal lab values. It seeks to restore functional capacity, cognitive clarity, and metabolic resilience in a way that reflects the dynamic biology of the human system. [1]
Read now
Brain Fog and Autoimmune Encephalitis: A Window Into Immune-Driven Cognitive Dysfunction
Cognitive dysfunction does not require neuron loss. It can arise from reversible interference with how brain cells communicate. Brain fog may reflect the same underlying biology, existing on a spectrum of immune-related synaptic disruption, rather than as a fundamentally different process. Autoimmune encephalitis is a neuroinflammatory condition in which immune responses target components of the central nervous system. This condition often causes problems with memory, attention, processing speed, and behavior, which frequently emerge before dramatic neurological signs develop. These changes can occur even when brain imaging is normal and before irreversible injury is present. [1][2]
Read now
Homocysteine and Thyroid Disease: Making the Connection
Homocysteine is generated during methionine metabolism as part of one-carbon and methylation pathways. When those pathways are strained, homocysteine can accumulate, which is often correlated with thyroid disease. Elevated homocysteine in individuals with thyroid dysfunction, homocysteine may signal several imbalances in the body such as increased methylation demand, metabolic slowing or inflammatory stress affecting hormone activation at the tissue level [1]. Homocysteine levels can provide insight into the broader metabolic context in which thyroid dysfunction develops and persist
Read now
Anti-depressant Non-Response: Why They Sometimes Fall Short
For many individuals with depression, antidepressant medications lead to meaningful improvement. For others, symptoms persist despite appropriate dosing and duration. This pattern is often referred to as “antidepressant non-response. New research has started to suggest that methylation should become a greater focus in an adjunctive nutritional approach in individuals who do not respond optimally to antidepressant monotherapy. There is also growing evidence that inflammatory and metabolic factors may help identify those most likely to benefit from this adjunctive approach.* [1]
Read now
L-Methylfolate and Its Role in Mood Support*
While antidepressant medications remain an important tool for many individuals, responses vary widely. For some, improvement is partial or plateaus over time, highlighting the complexity of mood biology rather than the failure of any single approach. Rather than indicating inadequacy of medication, this variability reflects the reality that mood regulation is not governed by a single pathway. When neurotransmitter signaling is supported without adequate upstream metabolic support, progress may be limited. [1] This understanding has opened the door to adjunctive approaches that focus on the biological conditions required for neurotransmitter production, not just receptor activity.
Read now
